Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1) - PubMed (original) (raw)

Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1)

S B Mizel et al. Proc Natl Acad Sci U S A. 1981 Apr.

Abstract

Human macrophages produce in culture a factor termed mononuclear cell factor (MCF) that increases the production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. A factor with similar biologic activity is also produced by the murine macrophage cell line P388D1. By using a sequential purification scheme involving ammonium sulfate fractionation; chromatography on DEAE-cellulose, Sephacryl S-200, and phenyl-Sepharose; and discontinuous polyacrylamide gel electrophoresis, the P388D1 cell-derived, synovial cell-stimulating factor was copurified with the lymphocyte-activating factor [LAF; interleukin 1 (IL 1)]. The specific activity of the partially purified LAF (IL 1) was approximately 15,000-fold higher than that of the LAF (IL 1) in the original P388D1 cell culture supernatant. On the basis of (i) the copurification of the P388D1 cell-derived LAF (IL 1) and synovial cell-stimulating factors; (ii) the similarity in cell of origin, molecular weight, and phenylglyoxal sensitivity of human MCF and murine LAF (IL 1); and (iii) the presence of LAF (IL 1) activity in preparations of partially purified human MCF, we have postulated that LAF (IL 1) may have effects on cell targets that are nonlymphoid in nature and also that human MCF may be similar to, or identical with human LAF (IL 1). The results of these studies have raised the possibility that LAF (IL 1) may play a role in macrophage-mediated activation of synovial cells and lymphocytes which are involved in the inflammatory responses associated with rheumatoid arthritis.

PubMed Disclaimer

Cited by

Recombinant human interleukin-1 alpha and recombinant human interleukin-1 beta stimulate cartilage matrix degradation and inhibit glycosaminoglycan synthesis.
Smith RJ, Rohloff NA, Sam LM, Justen JM, Deibel MR, Cornette JC. Smith RJ, et al. Inflammation. 1989 Aug;13(4):367-82. doi: 10.1007/BF00914921. Inflammation. 1989. PMID: 2668162
Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes.
Goldring MB, Birkhead J, Sandell LJ, Kimura T, Krane SM. Goldring MB, et al. J Clin Invest. 1988 Dec;82(6):2026-37. doi: 10.1172/JCI113823. J Clin Invest. 1988. PMID: 3264290 Free PMC article.
Identification of a high-affinity receptor for interleukin 1 alpha and interleukin 1 beta on cultured human rheumatoid synovial cells.
Chin J, Rupp E, Cameron PM, MacNaul KL, Lotke PA, Tocci MJ, Schmidt JA, Bayne EK. Chin J, et al. J Clin Invest. 1988 Aug;82(2):420-6. doi: 10.1172/JCI113614. J Clin Invest. 1988. PMID: 2969918 Free PMC article.
Reconciling the effects of inflammatory cytokines on mesenchymal cell osteogenic differentiation.
Deshpande S, James AW, Blough J, Donneys A, Wang SC, Cederna PS, Buchman SR, Levi B. Deshpande S, et al. J Surg Res. 2013 Nov;185(1):278-85. doi: 10.1016/j.jss.2013.06.063. Epub 2013 Aug 6. J Surg Res. 2013. PMID: 23972621 Free PMC article. Review.

References

1. Proc Natl Acad Sci U S A. 1976 Mar;73(3):945-9 - PubMed
1. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
1. J Exp Med. 1977 May 1;145(5):1399-1404 - PubMed
1. Anal Biochem. 1978 May;86(1):142-6 - PubMed
1. Biochem Biophys Res Commun. 1978 Nov 14;85(1):490-6 - PubMed

Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1) - PubMed (original) (raw)